Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 19

Results For "CRE"

4733 News Found

Remdesivir production increased to 119 lakh vials per month
News | May 18, 2021

Remdesivir production increased to 119 lakh vials per month

Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60


Covaxin vaccine production to increase 7x by August 2021
News | April 18, 2021

Covaxin vaccine production to increase 7x by August 2021

The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021.


Pharma PLI to increase exports
Policy | April 14, 2021

Pharma PLI to increase exports

Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28


Promoters of Lincoln Pharma increases holding by 4.9%
News | April 01, 2021

Promoters of Lincoln Pharma increases holding by 4.9%

The promoter holding in the company has increased to 37.25%, a rise of 4.9% from 32.35% as of 31 March 2020


Need for integration of various regulatory agencies : Pharma secretary
News | March 26, 2021

Need for integration of various regulatory agencies : Pharma secretary

Integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy to navigate interface.


DSM increases price for polyamide 6 and 66 in EMEA
News | March 02, 2021

DSM increases price for polyamide 6 and 66 in EMEA

The price increases are due to the rising costs of raw materials.


AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial
Clinical Trials | June 09, 2026

AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial

At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint


SPI Pharma completes acquisition of Elementis Pharma
News | June 09, 2026

SPI Pharma completes acquisition of Elementis Pharma

Deal expands SPI Pharma’s manufacturing footprint in Germany, enhances pharmaceutical ingredient offerings, and reinforces focus on fast-growing digestive health market


FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion
News | June 09, 2026

FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion

Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California